ACAD - ACADIA PHARMACEUTICALS INC
22.4
-0.990 -4.420%
Share volume: 2,209,009
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$23.39
-0.99
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-06-2024 | 11-06-2024 | 02-27-2025 | 05-08-2025 | 08-06-2025 | 11-05-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 855.103 M | 914.099 M | 976.868 M | 1.188 B | 1.132 B | 1.226 B | 1.331 B | 1.564 B | |
| Current Assets | 675.296 M | 728.916 M | 788.284 M | 938.318 M | 870.942 M | 960.553 M | 1.076 B | 1.062 B | |
| Inventories | 61.936 M | 71.525 M | 61.041 M | 21.949 M | 22.948 M | 26.124 M | 29.097 M | 34.670 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 265.775 M | 323.808 M | 410.181 M | 436.404 M | 463.881 M | 508.359 M | 589.023 M | 641.991 M | |
| Total Receivables | 100.079 M | 110.393 M | 110.363 M | 104.695 M | 113.714 M | 119.686 M | 139.438 M | 148.231 M | |
| Current Cash | 204.745 M | 177.134 M | 155.149 M | 319.589 M | 217.696 M | 253.637 M | 257.996 M | 177.695 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 4.370 M | 4.144 M | 3.988 M | 4.215 M | 3.498 M | 3.547 M | 3.708 M | 7.511 M | |
| Other Assets | 169.667 M | 175.269 M | 184.596 M | 236.453 M | 257.924 M | 251.984 M | 241.170 M | 486.726 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 855.103 M | 914.099 M | 976.868 M | 1.188 B | 1.132 B | 1.226 B | 1.331 B | 1.564 B | |
| Total liabilities | 391.059 M | 397.399 M | 399.688 M | 454.963 M | 367.127 M | 403.173 M | 413.499 M | 336.805 M | |
| Total current liabilities | 330.597 M | 337.851 M | 343.945 M | 394.870 M | 302.530 M | 330.024 M | 356.584 M | 277.114 M | |
| Accounts Payable | 19.332 M | 19.882 M | 19.081 M | 16.192 M | 18.095 M | 20.097 M | 21.747 M | 10.903 M | |
| Other liabilities | 11.273 M | 12.362 M | 55.743 M | 18.056 M | 64.597 M | 28.548 M | 13.889 M | 19.137 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 11.273 M | 12.362 M | 55.743 M | 18.056 M | 64.597 M | 28.548 M | 13.889 M | 19.137 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 464.044 M | 516.700 M | 577.180 M | 732.793 M | 765.237 M | 822.382 M | 917.272 M | 1.227 B | |
| Common stock | 2.879 B | 2.898 B | 2.924 B | 2.937 B | 2.950 B | 2.981 B | 3.003 B | 3.039 B | |
| Retained earnings | -2.414 B | -2.381 B | -2.348 B | -2.204 B | -2.185 B | -2.159 B | -2.087 B | -1.813 B |